华润双鹤,600062,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 分部间抵销,-3677,-3677,0,0%,0% 非输液,334315,104943,229371,68.61%,73.22% 输液,155918,72039,83879,53.8%,26.78% 华润双鹤,600062,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 专科业务平台,84603,22726,61876,73.14%,11.87% 输液业务平台,281781,130767,151013,53.59%,28.98% 其他(补充),13700,12505,1195,8.72%,0.23% 慢病业务平台,300809,50013,250796,83.37%,48.13% 其他,141616,85431,56186,39.67%,10.78% 华润双鹤,600062,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 输液,147595,68458,79137,53.62%,29.93% 分部间抵销,-1063,-1063,0,0%,0% 非输液,262236,76980,185256,70.64%,70.07% 华润双鹤,600062,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),15561,9742,5819,37.39%,1.58% 其他,103899,71743,32156,30.95%,8.72% 专科业务平台,53443,18046,35398,66.23%,9.6% 输液业务平台,231847,127785,104062,44.88%,28.22% 慢病业务平台,237435,46059,191376,80.6%,51.89% 华润双鹤,600062,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 分部间抵销,-757,-757,0,0%,0% 输液,109588,62397,47191,43.06%,27.4% 非输液,198758,73742,125016,62.9%,72.6% 华润双鹤,600062,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),12781,7034,5747,44.96%,1.97% 其他,63728,54784,8944,14.03%,3.06% 儿科用药,25827,6762,19065,73.82%,6.53% 内分泌,25384,8087,17297,68.14%,5.93% 输液,210668,127394,83274,39.53%,28.54% 心脑血管,211092,53588,157504,74.61%,53.97% 华润双鹤,600062,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 儿科用药,11877,3599,8279,69.7%,5.61% 心脑血管,111343,28306,83037,74.58%,56.24% 其他(补充),5480,2615,2865,52.29%,1.94% 其他,33552,30980,2573,7.67%,1.74% 内分泌,13311,4282,9029,67.83%,6.11% 输液,109027,67153,41874,38.41%,28.36% 华润双鹤,600062,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),16019,8388,7631,47.64%,2.86% 其他,41250,35820,5430,13.16%,2.04% 儿科用药,21778,5655,16123,74.03%,6.05% 内分泌,24120,7758,16362,67.84%,6.14% 心脑血管,178721,39222,139499,78.05%,52.34% 输液,231951,150469,81482,35.13%,30.57% 华润双鹤,600062,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2476,1380,1096,44.27%,1.02% 输液,120876,78308,42568,35.22%,39.68% 非输液,87331,23724,63608,72.83%,59.3% 华润双鹤,600062,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4937,2422,2515,50.93%,1.21% 输液产品,256070,171603,84467,32.99%,40.71% 非输液产品,167089,46573,120516,72.13%,58.08% 华润双鹤,600062,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2347,-- ,-- ,--,0% 药品,213786,110917,102869,48.12%,100% 华润双鹤,600062,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),6358,-- ,-- ,--,0% 其中:输液产品,267616,160496,107120,40.03%,23.66% 其中:非输液产品,155787,42445,113341,72.75%,25.03% 药品,677099,444726,232373,34.32%,51.32% 华润双鹤,600062,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3735,-- ,-- ,--,0% 药品,377467,255712,121755,32.26%,100% 华润双鹤,600062,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),7640,3222,4418,57.83%,1.9% 药品,691292,462923,228369,33.04%,98.1% 华润双鹤,600062,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3542,1381,2160,61%,1.89% 其中:关联交易,6182,-- ,-- ,--,0% 药品,366677,254480,112197,30.6%,98.11% 华润双鹤,600062,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),7974,6922,1052,13.19%,0.51% 药品,630363,425224,205139,32.54%,99.49% 华润双鹤,600062,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3223,-- ,-- ,--,0% 大输液,77911,49240,28670,36.8%,30.38% 制剂药品(不含大输液),89248,23541,65707,73.62%,69.62% 华润双鹤,600062,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,152324,90128,62196,40.83%,35.11% 制剂药品(不含大输液),162725,47752,114973,70.65%,64.89% 华润双鹤,600062,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,71981,42869,29112,40.44%,32.86% 制剂药品(不含大输液),83157,23673,59485,71.53%,67.14% 华润双鹤,600062,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,129991,79620,50371,38.75%,33.36% 制剂药品(不含大输液),142669,42041,100628,70.53%,66.64% 华润双鹤,600062,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,60103,37751,22352,37.19%,29.92% 制剂药品(不含大输液),73222,20868,52354,71.5%,70.08% 华润双鹤,600062,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,117064,73793,43271,36.96%,32.64% 制剂药品(不含大输液),127173,37892,89281,70.2%,67.36% 华润双鹤,600062,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,54422,33335,21087,38.75%,35.42% 制剂药品(不含大输液),54253,15803,38449,70.87%,64.58% 华润双鹤,600062,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,94910,58848,36062,38%,31.47% 制剂药品(不含大输液),111339,32800,78539,70.54%,68.53% 华润双鹤,600062,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,44009,28084,15925,36.19%,30.3% 制剂药品,52102,15461,36641,70.33%,69.7% 华润双鹤,600062,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,73030,94885,-21855,-29.93%,-49.96% 制剂药品(不含大输液),94885,29287,65598,69.13%,149.96% 华润双鹤,600062,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,52870,34950,17920,33.89%,25.19% 制剂药品,76420,23200,53220,69.64%,74.81% 华润双鹤,600062,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,31837,21058,10779,33.86%,23.91% 制剂药品(不含大输液),48802,14507,34295,70.27%,76.09% 华润双鹤,600062,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,14418,9629,4789,33.22%,18.89% 制剂药品(不含大输液),29448,8879,20570,69.85%,81.11% 华润双鹤,600062,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,65821,42408,23413,35.57%,26.84% 制剂药品(不含大输液),91931,28105,63825,69.43%,73.16% 华润双鹤,600062,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,48206,31309,16897,35.05%,23.36% 制剂药品(不含大输液),76013,20586,55427,72.92%,76.64% 华润双鹤,600062,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,30823,20264,10559,34.26%,24.55% 制剂药品(不含大输液),43366,10909,32457,74.84%,75.45% 华润双鹤,600062,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,12919,8809,4110,31.81%,27.82% 制剂药品(不含大输液),16015,5351,10663,66.59%,72.18% 华润双鹤,600062,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药设备,5219,0,5219,100%,3.22% 天然药品,11425,0,11425,100%,7.04% 大输液,58965,0,58965,100%,36.34% 制剂药品,86634,0,86634,100%,53.4% 华润双鹤,600062,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,52576,36581,15995,30.42%,24.74% 制剂药品(不含大输液),70645,21985,48660,68.88%,75.26% 华润双鹤,600062,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,29763,19770,9993,33.58%,25.38% 制剂药品(不含大输液),42378,13002,29376,69.32%,74.62% 华润双鹤,600062,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,13298,8836,4463,33.56%,20.8% 制剂药品(不含大输液),26451,9456,16995,64.25%,79.2% 华润双鹤,600062,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药设备,5836,0,5836,100%,5.41% 天然药品,25968,11620,14348,55.25%,13.29% 原料药,12740,0,12740,100%,11.8% 大输液,64964,44333,20631,31.76%,19.11% 制剂药品(不含大输液),79764,25356,54408,68.21%,50.4% 华润双鹤,600062,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 天然药,6011,2926,3085,51.32%,15.97% 大输液,19298,11968,7329,37.98%,37.95% 制剂药品(不含大输液),13934,5034,8899,63.87%,46.08% 华润双鹤,600062,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 天然药品,13916,6740,7175,51.56%,17.37% 大输液,36844,22184,14659,39.79%,35.49% 制剂药品(不含大输液),30625,11154,19472,63.58%,47.14% 华润双鹤,600062,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 大输液,13588,8944,4644,34.17%,29.66% 制剂药品(不含大输液),17164,6153,11011,64.15%,70.34% 华润双鹤,600062,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药设备,4446,0,4446,100%,2.35% 天然药品,18756,0,18756,100%,9.91% 原料药,18346,0,18346,100%,9.7% 大输液,67991,0,67991,100%,35.93% 制剂药品(不含大输液),79670,0,79670,100%,42.11% 华润双鹤,600062,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药装备,1726,1063,663,38.41%,1.54% 原料药,8931,7152,1779,19.92%,4.13% 天然药品,9924,4319,5605,56.48%,13% 大输液,38254,22050,16204,42.36%,37.59% 制剂药品(不含大输液),27621,8762,18859,68.28%,43.75% 华润双鹤,600062,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药装备,2898,0,2898,100%,2.26% 天然药品,7790,0,7790,100%,6.08% 原料药,18602,0,18602,100%,14.51% 大输液,48935,0,48935,100%,38.17% 制剂药品(不含大输液),49989,0,49989,100%,38.99%